Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia
Hoelzer, D.; Thiel, E.; Löffler, H.; Büchner, T.; Ganser, A.; Heil, G.; Kurrle, E.; Heimpel, H.; Koch, P.; Lipp, T.
Seminars in Oncology 14(2 Suppl 1: 92-97
1987
ISSN/ISBN: 0093-7754 PMID: 3473688 Document Number: 291403
Document emailed within 1 workday
Related Documents
Takemoto, Y.; Sampi, K.; Kuraishi, Y.; Okabe, K.; Tamura, K.; Mizoguchi, H.; Saito, H.; Masaoka, T.; Ogawa, M. 1999: A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. the KRN8602 Leukemia Study Group International Journal of Hematology 70(1): 20-25Gingrich, R.D.; Armitage, J.O.; Burns, C.P. 1978: Treatment of adult acute lymphoblastic leukemia with cytosine arabinoside, vincristine, and prednisone Cancer Treatment Reports 62(9): 1389-1391
Hines, J.D.; Mazza, J.J.; Oken, M.M.; Bennett, J.M.; Adelstein, D.J.; Keller, A.; O'Connell, M.J. 1985: High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase i Pilot Study for the Eastern Cooperative Oncology Group Seminars in Oncology 12(2 Suppl 3: 117-119
Sanz, M.A.; Martínez, J.; Borrego, D.; Martín-Aragonés, G.; Lorenzo, I.; Sanz, G.; Sayas, M.J.; Jarque, I.; Pastor, E.; Rafecas, J. 1987: High-dose cytosine arabinoside and mitoxantrone in high-risk acute nonlymphoblastic leukemia Seminars in Oncology 14(2 Suppl 1): 18-20
Ohshima, A.; Yoshida, K.; Sato, T.; Miyazaki, S.; Yanagisawa, M.; Nakayama, Y.; Takahashi, T.; Mamiya, S.; Fukusima, Y.; Miura, A.B. 1987: Intermediate- and high-dose cytosine arabinoside therapy in acute refractory leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(1): 192-195
Weyman, C.; Graham-Pole, J.; Emerson, S.; August, C.; Champlin, R.; Coccia, P.; Fay, J.; Harris, R.; Koch, P.; Johnson, L. 1993: Use of cytosine arabinoside and total body irradiation as conditioning for allogeneic marrow transplantation in patients with acute lymphoblastic leukemia: a multicenter survey Bone Marrow Transplantation 11(1): 43-50
Harakati, M.S. 1999: Cytosine arabinoside, mitoxantrone, and etoposide in the treatment of adult patients with previously untreated acute myeloid leukemia Saudi Medical Journal 20(4): 291-295
Burns, C.P. 1975: Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia Cancer ChemoTherapy Reports 59(4): 757-760
Kansu, E.; Koc, Y.; Kars, A.; Alakavuklar, M.; Tekuzman, G.; Firat, D. 1989: Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report Journal of ChemoTherapy 1(4 Suppl): 1268-1270
Krance, R.A.; Forman, S.J.; Blume, K.G. 1987: Total-body irradiation and high-dose teniposide: a pilot study in bone marrow transplantation for patients with relapsed acute lymphoblastic leukemia Cancer Treatment Reports 71(6): 645-647
Arlin, Z.; Case, D.C.; Moore, J.; Wiernik, P.; Feldman, E.; Saletan, S.; Desai, P.; Sia, L.; Cartwright, K. 1990: Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group Leukemia 4(3): 177-183
Sanz, G.F.; Sanz, M.A.; Rafecas, F.J.; Martínez, J.A.; Martín-Aragonés, G.; Marty, M.L. 1986: Teniposide and cytarabine combination chemotherapy in the treatment of relapsed adolescent and adult acute lymphoblastic leukemia Cancer Treatment Reports 70(11): 1321-1323
Nemet, D.; Labar, B.; Bogdanić, V.; Hauptman, E.; Jaksić, B.; Minigo, H.; Sertić, D.; Mrsić, M.; Pavletić, Z.; Kovacević, J. 1989: High dose cytosine arabinoside in the treatment of adult acute myelogenous leukaemia Bone Marrow Transplantation 4(Suppl 3): 42-44
Wysocki, M.; Nowaczyk-Michalak, A.; Pilecki, O.; Trybuś, L.; Balcar-Boroń, A. 1992: Jaundice following high--dose arabinoside cytosine in a child with acute myelogenous leukemia Acta Haematologica Polonica 23(3): 197-199
Cetkovský, P.; Koza, V.; Cepelák, V.; Vít, L. 1994: Hemostasis in patients with acute leukemia treated with high doses of cytosine-arabinoside: the effect of chemotherapy and infectious complications on hemostasis Vnitrni Lekarstvi 40(11): 730-734
Bodey, G.P.; Rodriguez, V.; Hart, J.; Freireich, E.J. 1970: Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271) Cancer ChemoTherapy Reports 54(4): 255-262
Herzig, R.H.; Coccia, P.F.; Lazarus, H.M.; Strandjord, S.E.; Graham-Pole, J.; Cheung, N.K.; Gordon, E.M.; Gross, S.; Spitzer, T.R.; Warkentin, P.I. 1985: Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation Seminars in Oncology 12(2 Suppl 3: 184-186
Taguchi, H.; Kubonishi, I.; Takehara, N.; Uemura, Y.; Iwahara, Y.; Eguchi, T.; Miyagi, T.; Sugito, S.; Muneishi, H.; Tanaka, Y. 1992: Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(9): 1309-1314
Invernizzi, R.; Pecci, A.; Rossi, G.; Pelizzari, A.M.; Giusto, M.; Tinelli, C.; Ascari, E. 1997: Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes Haematologica 82(6): 660-663
Avilés-Miranda, A.; Monroy-Arellano, L.M.; Conte-Lanza, G.; Morales-Polanco, M.R.; Pizzuto-Chávez, J. 1980: Combined chemotherapy: prednisone, cytosine arabinose and vincristine in the treatment of acute non-lymphoblastic leukemia in the adult Gaceta Medica de Mexico 116(8): 359-364